SCHEMBL3377451

SCHEMBL3377451

CSCCNC(=O)c1cccc(OS(C)(=O)=O)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 7/20 0.40
HCRTR1 O43613 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 3/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.38
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377448 0.91 MEN1 (0.41) MEN1KMT2AKDM4EALDH1A1PKM
SCHEMBL3377883 0.89 HCRTR1 (0.41) MEN1KMT2AKDM4EALDH1A1PKM
SCHEMBL3375839 0.88 ALDH1A1 (0.45) MEN1KMT2AKDM4EALDH1A1PKM
SCHEMBL3374783 0.87 MEN1 (0.40) MEN1KMT2AKDM4EALDH1A1PKM
SCHEMBL3377283 0.86 HCRTR1 (0.45) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL3376166 0.84 TSHR (0.54) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL5716646 0.81 KCNA3 (0.40) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL3377865 0.81 POLB (0.48) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL3377879 0.80 MEN1 (0.39) MEN1KMT2AKDM4EALDH1A1PKM
SCHEMBL550872 0.80 MEN1 (0.39) MEN1KMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 MEN1 1772/4885KMT2A 102/4885KDM4E 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.